Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TYO/2929 stock hub

TYO/2929 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/2929is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.9B

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/2929

In the news

Latest news · TYO/2929

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.4

P25 12.7P50 15.8P75 21.7

Trailing P/En/a

P25 11.7P50 15.2P75 22.3

ROE-15.4

P25 -1.6P50 7.1P75 11.9

ROIC-3.8

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/2929 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

JPY

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	613
Employees Change	-29%
Employees Change Percent	-4.52
Enterprise value	JPY 25.1B
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	JP3802310007
Last refreshed	2026-05-10
Market cap	JPY 17.9B
Price	JPY 618
Price currency	JPY
Rev Per Employee	110,675,367.05x
Sector	Healthcare
Sic	2834
Symbol	tyo/2929
Website	https://www.pharmafoods.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.39%
EV Earnings	-14.9x
EV/EBITDA	256.26x
EV/FCF	-5.2x
EV/Sales	0.37x
FCF yield	-26.9%
Forward P/E	11.4x
P/B ratio	1.84x
P/S ratio	0.26x
PE Ratio10 Y	99.53x
PE Ratio3 Y	30.21x
PE Ratio5 Y	27.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.91%
EBITDA Margin	0.21%
Gross margin	80.47%
Gross Profit	JPY 54.6B
Gross Profit Growth	13.89%
Gross Profit Growth Q	10.36%
Gross Profit Growth3 Y	0.7%
Gross Profit Growth5 Y	17.53%
Net Income	JPY -1.7B
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-1.12%
Profit Margin	-2.48%
Profit Per Employee	JPY -2.7M
Profitable Years	3
ROA	-1.18
Roa5y	9.04
ROCE	-5.82
ROE	-15.45
Roe5y	24.59
ROIC	-3.78
Roic5y	26.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.69%
Cagr15y	20.59%
Cagr1y	-31.98%
Cagr3y	-26.31%
Cagr5y	-27.46%
Div CAGR3	4.35%
Div CAGR5	0%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	12.41x
Revenue Growth Q	9.62x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	0.67x
Revenue Growth5 Y	18.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	JPY 2.08
Assets	JPY 32.3B
Cash	JPY 7.7B
Current Assets	JPY 22.3B
Current Liabilities	JPY 21.7B
Debt	JPY 14.9B
Debt EBITDA	JPY 103
Debt Equity	JPY 1.52
Debt FCF	JPY -3.08
Equity	JPY 9.8B
Interest Coverage	-5.65
Liabilities	JPY 22.5B
Long Term Assets	JPY 9.9B
Long Term Liabilities	JPY 819M
Net Cash	JPY -7.2B
Net Cash By Market Cap	JPY -39.92
Net Debt EBITDA	JPY 49.76
Net Debt Equity	JPY 0.73
Tangible Book Value	JPY 9.7B
Tangible Book Value Per Share	JPY 333
WACC	3.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.03
Inventory Turnover	1.64
Net Working Capital	JPY 7.5B
Quick ratio	0.57
Working Capital	JPY 679M
Working Capital Turnover	JPY 30.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.29%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	JPY 25
Dividend Years	7
Dividend Yield	4.05%
Ex Div Date	2026-07-30
Last Dividend	JPY 12.5
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	43.65%
1Y total return	-31.96%
200-day SMA	763.1
3Y total return	-60%
50-day SMA	655.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.91%
All Time High	3,820
All Time High Change	-83.82%
All Time High Date	2021-04-02
All Time Low	32.5
All Time Low Change	1,801.54%
All Time Low Date	2008-10-28
ATR	19.46
Beta	0.32
Beta1y	0.08
Beta2y	0.45
Ch YTD	-8.98
High	625
High52	1,064
High52 Date	2025-09-10
High52ch	-41.92%
Low	615
Low52	560
Low52 Date	2026-03-09
Low52ch	10.36%
Ma50ch	-5.68%
Price vs 200-day SMA	-19.02%
RSI	33.94
RSI Monthly	34.4
RSI Weekly	36.16
Sharpe ratio	-0.9x
Sortino ratio	-1.03
Total Return	1.75%
Tr YTD	-7.25
Tr15y	1,558.17%
Tr1m	-13.08%
Tr1w	-2.98%
Tr3m	-6.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY -616M
Operating margin	-0.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,507,867%
Net Borrowing	2,406,000,000
Shares Insiders	23.25%
Shares Institutions	31.16%
Shares Out	29,043,377
Shares Qo Q	0.32%
Shares Yo Y	2.29%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	JPY -4.8B
Average Volume	183,945x
Bv Per Share	336.4
CAPEX	JPY -936M
Ch10y	28.75
Ch15y	1,386.3
Ch1m	-13.08
Ch1w	-2.98
Ch1y	-34.19
Ch3m	-6.79
Ch3y	-62.93
Ch5y	-81.8
Ch6m	-22.85
Change	-0.8%
Change From Open	-1.12
Close	623
Days Gap	0.32
Depreciation Amortization	760,000,000
Dollar Volume	85,963,800
Earnings Date	2026-06-10
EBIT	JPY -616M
EBITDA	JPY 144M
EPS	JPY -58.22
F Score	3
FCF	JPY -4.8B
FCF EV Yield	-19.23x
FCF Per Share	JPY -166
Financing CF	1,497,000,000
Fiscal Year End	July
Founded	1,997
Goodwill	54,000,000
Income Tax	JPY 925M
Investing CF	-1,024,000,000
Is Primary Listing	1
Last Earnings Date	2026-03-13
Last Report Date	2026-01-31
Last Split Date	2015-01-28
Last Split Type	Forward
Ma150	713.5
Ma150ch	-13.39%
Ma20	669.9
Ma20ch	-7.74%
Net CF	-3,420,000,000
Next Earnings Date	2026-06-10
Open	625
Payment Date	2026-10-28
Position In Range	30
Ppne	4,837,000,000
Price Date	2026-05-08
Price EBITDA	JPY 125
Ptbv Ratio	1.86
Relative Volume	0.77x
Revenue	67,844,000,000x
Tax By Revenue	1.36x
Tr6m	-21.38%
Volume	139,100
Z Score	2.96

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TYO/2929 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.0%

$25.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2026-07-30

Performance

TYO/2929 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/2929?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.2%

Share of float held by funds and institutions

Insider ownership

+23.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.3%

Negative means the company is buying back shares.

Technical

TYO/2929 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.9

Neutral momentum band

Price vs 200-day MA

-19.0%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

-0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/2929

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/2929 stock rating?

tyo/2929 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/2929 analysis?

The full report lives at /stocks/tyo/2929/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/2929?

The latest report frames tyo/2929 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/2929 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.